http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106632145-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
filingDate 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106632145-B
titleOfInvention Novel preparation method of vortioxetine hydrobromide crystal form α
abstract The invention relates to a new preparation method of vortioxetine hydrobromide crystal form α, which comprises the following steps: dissolving vortioxetine hydrobromide in a good solvent, adding dropwise to the poor solvent at low temperature, and crystallizing Obtain crystal form α. The method has the advantages of high yield, high purity, low energy consumption, simple operation, safety and environmental protection, good reproducibility and the like, and is especially suitable for the requirements of large-scale chemical production in the pharmaceutical and chemical industry.
priorityDate 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21477393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410491816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56843850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453390375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410437773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9966051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452505798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413

Total number of triples: 39.